# Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

> **NCT00975533** · PHASE3 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 24 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** Tantalus
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00975533
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975533, "Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00975533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*